Nagoya, Japan

Shuta Tomita

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Shuta Tomita: Pioneering Innovations in Lung Cancer Genomics**

Introduction

Shuta Tomita, based in Nagoya, Japan, is an innovative inventor known for her significant contributions to the field of medical genomics. With a total of two patents to her name, her work primarily focuses on methods for classifying gene expression strength, particularly in lung cancer tissues. Through her inventions, she aims to enhance the decision-making process regarding patient survival rates in clinical settings.

Latest Patents

Shuta Tomita's latest inventions include a method of classifying gene expression strength in lung cancer tissues. This method provides a means of confirming gene expression, which is essential for determining the five-year survival rate of lung cancer patients. The process includes the use of a DNA probe kit to assess the expression strength of one or more genes in lung cancer tissues isolated from patients. Her work represents a vital advancement in understanding and treating non-small cell lung cancer.

Career Highlights

Throughout her career, Shuta has worked with notable companies, such as Aichi Prefecture and Fujifilm Corporation. Her experiences in these organizations have allowed her to develop innovative solutions that address crucial challenges in cancer treatment and diagnostics.

Collaborations

Shuta Tomita has collaborated with esteemed colleagues, including Takashi Takahashi and Tetsuya Mitsudomi. Their joint efforts reflect a commitment to advancing medical research and improving patient outcomes through innovative gene expression analysis techniques.

Conclusion

Shuta Tomita's contributions to the fields of genomics and cancer research underscore the importance of innovation in improving health outcomes. Her patented methods for classifying gene expression in lung cancer tissues not only pave the way for more informed clinical decisions but also highlight her dedication to enhancing survival rates for patients. As an inventor, Shuta Tomita continues to inspire future advancements in cancer research and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…